676 related articles for article (PubMed ID: 24346827)
1. The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension.
Marcus JA; Pothineni A; Marcus CZ; Bisognano JD
Curr Hypertens Rep; 2014 Jan; 16(1):411. PubMed ID: 24346827
[TBL] [Abstract][Full Text] [Related]
2. Management of Hypertension in Obstructive Sleep Apnea.
Furlan SF; Braz CV; Lorenzi-Filho G; Drager LF
Curr Cardiol Rep; 2015 Dec; 17(12):108. PubMed ID: 26482751
[TBL] [Abstract][Full Text] [Related]
3. Obstructive Sleep Apnea-Induced Neurogenic Nocturnal Hypertension: A Potential Role of Renal Denervation?
Kario K; Hettrick DA; Prejbisz A; Januszewicz A
Hypertension; 2021 Apr; 77(4):1047-1060. PubMed ID: 33641363
[TBL] [Abstract][Full Text] [Related]
4. Sleep-disordered breathing and resistant hypertension.
Wang AY
Semin Nephrol; 2014; 34(5):520-31. PubMed ID: 25416661
[TBL] [Abstract][Full Text] [Related]
5. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects.
Phillips CL; Cistulli PA
Minerva Med; 2006 Aug; 97(4):299-312. PubMed ID: 17008835
[TBL] [Abstract][Full Text] [Related]
6. Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management.
Salman LA; Shulman R; Cohen JB
Curr Cardiol Rep; 2020 Jan; 22(2):6. PubMed ID: 31955254
[TBL] [Abstract][Full Text] [Related]
7. Hypertension in obstructive sleep apnea: risk and therapy.
Das AM; Khayat R
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):619-26. PubMed ID: 19505277
[TBL] [Abstract][Full Text] [Related]
8. Non-dipping pattern of hypertension and obstructive sleep apnea syndrome.
Wolf J; Hering D; Narkiewicz K
Hypertens Res; 2010 Sep; 33(9):867-71. PubMed ID: 20818398
[TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnoea, resistant hypertension and renal denervation.
Witkowski A; Kadziela J
EuroIntervention; 2013 May; 9 Suppl R():R105-9. PubMed ID: 23732140
[TBL] [Abstract][Full Text] [Related]
10. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: A systematic review of randomized clinical trials.
Feldstein CA
Clin Exp Hypertens; 2016; 38(4):337-46. PubMed ID: 27159803
[TBL] [Abstract][Full Text] [Related]
12. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.
Muxfeldt ES; Margallo V; Costa LM; Guimarães G; Cavalcante AH; Azevedo JC; de Souza F; Cardoso CR; Salles GF
Hypertension; 2015 Apr; 65(4):736-42. PubMed ID: 25601933
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional relationship of hypertension with obstructive sleep apnea.
Jhamb M; Unruh M
Curr Opin Pulm Med; 2014 Nov; 20(6):558-64. PubMed ID: 25203003
[TBL] [Abstract][Full Text] [Related]
14. Obstructive sleep apnea syndrome, continuous positive airway pressure and treatment of hypertension.
Floras JS
Eur J Pharmacol; 2015 Sep; 763(Pt A):28-37. PubMed ID: 26096557
[TBL] [Abstract][Full Text] [Related]
15. [Obstructive sleep apnea-related cardiovascular disease].
Schulz R; Grebe M; Eisele HJ; Mayer K; Weissmann N; Seeger W
Med Klin (Munich); 2006 Apr; 101(4):321-7. PubMed ID: 16607489
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous positive airway pressure therapy on daytime and nighttime arterial blood pressure in patients with severe obstructive sleep apnea and endothelial dysfunction.
Bischof F; Egresits J; Schulz R; Randerath WJ; Galetke W; Budweiser S; Nilius G; Arzt M; Hetzenecker A;
Sleep Breath; 2020 Sep; 24(3):941-951. PubMed ID: 31463779
[TBL] [Abstract][Full Text] [Related]
17. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial.
Martínez-García MA; Capote F; Campos-Rodríguez F; Lloberes P; Díaz de Atauri MJ; Somoza M; Masa JF; González M; Sacristán L; Barbé F; Durán-Cantolla J; Aizpuru F; Mañas E; Barreiro B; Mosteiro M; Cebrián JJ; de la Peña M; García-Río F; Maimó A; Zapater J; Hernández C; Grau SanMarti N; Montserrat JM;
JAMA; 2013 Dec; 310(22):2407-15. PubMed ID: 24327037
[TBL] [Abstract][Full Text] [Related]
18. Vascular responses to hypoxia are not impaired in obstructive sleep apnoea patients free of overt cardiovascular disease.
Beaudin AE; Hanly PJ; Raneri JK; Sajobi TT; Anderson TJ; Poulin MJ
Exp Physiol; 2019 Apr; 104(4):580-600. PubMed ID: 30697840
[TBL] [Abstract][Full Text] [Related]
19. Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome.
Kuklisova Z; Tkacova R; Joppa P; Wouters E; Sastry M
Sleep Med; 2017 Feb; 30():139-145. PubMed ID: 28215237
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.
White LH; Bradley TD; Logan AG
J Hum Hypertens; 2015 Jun; 29(6):342-50. PubMed ID: 25339298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
